Medical biotechnology : Nanomedicine

Basic

• Nanomedicine: Technologies and Applications / ed. Thomas J Webster. 2nd Edition - Elsevier, 2023, 9780128186275 Catalogue

Additional:

• Bradbury, A.R.M.; Sidhu, S.; Dübel, S.; McCafferty, J. Beyond the natural antibodies: the power of in vitro display technologies. Nat. Biotechnol., 2011, 29, 245-254. http://doi.org/10.1038/nbt.1791
• Monegal, A.; Ami, D.; Martinelli, C.; Huang, H.; Aliprandi, M.; Capasso, P.; Francavilla, C.; Ossolengo, G.; de Marco, A. Immunological applications of single domain llama recombinant antibodies isolated from a naïve library. Prot. Engineer. Des. Sel., 2009, 22, 273-280. https://doi.org/10.1093/protein/gzp002 E-version
• Vaneycken, I.; D’huyvetter, M.; Hernot, S.; De Vos, J.; Xavier, C.; Devoogdt, N.; Caveliers, V.; Lahoutte, T. Immuno-imaging using nanobodies. Curr. Op. Biotechnol., 2011, 22, 1-5. https://doi.org/10.1016/j.copbio.2011.06.009 E-version
• Jain, R.K. Transport of molecules in the tumor interstitium: a review. Cancer Res., 1987, 47, 3039-3051. E-version
• Vosjan, M.J.; Vercammen, J.; Kolkman, J.A.; Stigter-van Walsum, M.; Revets, H.; van Dongen, G.A. Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy. Mol. Cancer Ther., 2012, 11, 1017-1025. https://doi.org/10.1158/1535-7163.MCT-11-0891 E-version
• Oliveira, S.; Schiffelers, R.M.; van der Veeken, J.; van der Meel, R.; Vongpromek, R.; van Bergen En Henegouwen, P.M.; Storm, G.; Roovers, R.C. Downregulation of EGFR by a novel multivalent nanobody-liposome platform. J. Control. Release, 2010, 145, 165-175. https://doi.org/10.1016/j.jconrel.2010.03.020 E-version
• Shen, B.Q.: Xu, K.; Liu. L.; Raab. H.; Bhakta, S.; Kenrick, M.; Parsons-Reponte, K.L.; Tien, J.; Yu, S.F.; Mai, E.; Li, D.; Tibbitts, J.; Baudys, J.; Saad, O.M.; Scales, S.J.; McDonald, P.J.; Hass, P.E.; Eigenbrot, C.; Nguyen, T.; Solis, W.A.; Fuji, R.N.; Flagella, K.M.; Patel, D.; Spencer, S.D.; Khawli, L.A.; Ebens, A.; Wong, W.L.; Vandlen, R.; Kaur, S.; Sliwkowski, M.X.; Scheller, R.H.; Polakis, P.; Junutula, J.R. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates. Nat. Biotechnol., 2012, 30, 184-189. https://doi.org/10.1038/nbt.2108
• de Marco, A. 2014 Methodologies for the isolation of alternative binders with improved clinical potentiality over conventional antibodies. Crit. Rev. Biotech., 33(1):40-8 https://doi.org/10.3109/07388551.2012.665353 E-version
• de Marco A. 2013 Co-expression and co-purification of antigen-antibody complexes in bacterial cytoplasm and periplasm. Methods Mol Biol. 1129:125-35. https://doi.org/10.1007/978-1-62703-977-2_12
• Zou T, Dembele F, Beugnet A, Sengmanivong L, Trepout S, Marco S, de Marco A, Li M-H (2015) Nanobody-functionalized PEG-b-PCL polymersomes and their targeting study. J Biotechnology, 214:147-155 https://doi.org/10.1016/j.jbiotec.2015.09.034 E-version
• Crépin R, Gentien D, Duché A, Rapinat A, Reyes C, Némati F, Massonnet G, Decaudin D, Djender S, Moutel S, Desrumeaux K, Cassoux N, Piperno-Neumann S, Amigorena S, Perez F, Roman Roman S, de Marco A (2017) Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma Patient Derived Xenografts. Pigment Cell Melanoma Res, 30:317-327 https://doi.org/10.1111/pcmr.12577
• Ambrosetti E, Paoletti P, Bosco A, Parisse P, Scaini D, Tagliabue E, de Marco A, Casalis L (2017) Quantification of circulating cancer biomarkers via sensitive topographic measurements on single binder nanoarrays. ACS Omega, 2:2618-2629 https://doi.org/10.1021/acsomega.7b00284 E-version